Search results
Results from the WOW.Com Content Network
Johnson & Johnson has a global workforce of approximately 130,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato. Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready
In 1989, Duato began his career with Johnson & Johnson, joining Janssen Pharmaceuticals in Spain. [2] [5] After moving to the US in 2002, Duato was appointed executive vice president, worldwide chairman, pharmaceuticals in 2011. His growth strategy led to the turnaround of Johnson & Johnson’s struggling pharmaceutical business in the early ...
S. C. Johnson & Son, Inc. (commonly referred to as S. C. Johnson) is an American multinational corporation, privately held manufacturer of household cleaning supplies and other consumer chemicals based in Racine, Wisconsin. [1] In 2017, S. C. Johnson employed approximately 13,000 people and had estimated sales of $10 billion. [2]
The Suzanne Nora Johnson Stock Index From January 2008 to December 2012, if you bought shares in companies when Suzanne Nora Johnson joined the board, and sold them when she left, you would have a -46.0 percent return on your investment, compared to a -2.8 percent return from the S&P 500.
William C. Weldon (born November 26, 1948) is a former chairman of Johnson & Johnson, [1] He was the eighth chairman in Johnson & Johnson's history of more than one hundred years. [ 2 ] Early life and education
This meant that Johnson & Johnson retained about 90.9% of the shares after the IPO. [18] [19] The IPO took place on May 4, 2023. [20] Shares of Kenvue were priced at $22, [21] [22] [23] implying an initial equity valuation for Kenvue of about $41 billion, and traded at $26.90 at the end of the first trading day. [24]
This page was last edited on 11 December 2024, at 07:02 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
In September 2016, pharmaceutical and medical device company Johnson & Johnson announced they were buying Abbott Medical Optics for $4.3 billion. [13] On February 27, 2017, Abbott Medical Optics changed its name to Johnson & Johnson Vision following its $4.3 billion acquisition by Johnson & Johnson. [14] In 2017, JJV acquired TearScience. [15]